OLMA
Olema Pharmaceuticals, Inc. · Healthcare · Biotechnology
Momentum-inputs (vergelijkbare managers):
breedte van houders -7.1% ·
aandelenstroom -14.7% ·
netto nieuwe posities -7.7%
— formule
Brede distributie — dalende aandelen en minder houders
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q2 2025
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 77 | -5 | 48.00M | $600.59M | +5 | −10 |
| Q1 2026 | 85 | +7 | 50.63M | $755.34M | +15 | −8 |
| Q4 2025 | 78 | +3 | 39.80M | $995.19M | +3 | — |
| Q3 2025 | 16 | 0 | 15.07M | $147.57M | +1 | −1 |
| Q2 2025 | 13 | -1 | 13.76M | $58.63M | — | −1 |
| Q1 2025 | 11 | -1 | 8.23M | $30.93M | +1 | −2 |
| Q4 2024 | 12 | 0 | 11.47M | $66.81M | — | — |
| Q3 2024 | 11 | 0 | 7.78M | $92.93M | +1 | −1 |
| Q2 2024 | 11 | — | 6.52M | $70.59M | — | — |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (passief) | 4.61M | — | $19.62M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | BlackRock ✦ (passief) | 4.61M | — | $19.62M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | BlackRock ✦ (passief) | 4.61M | — | $19.62M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | BlackRock ✦ (passief) | 4.61M | — | $19.62M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | BlackRock ✦ (passief) | 4.61M | — | $19.62M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | BlackRock ✦ (passief) | 4.61M | — | $19.62M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | BlackRock ✦ (passief) | 4.61M | — | $19.62M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | BlackRock ✦ (passief) | 4.61M | — | $19.62M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | The Vanguard Group ✦ (passief) | 3.27M | — | $13.92M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | The Vanguard Group ✦ (passief) | 3.27M | — | $13.92M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | The Vanguard Group ✦ (passief) | 3.27M | — | $13.92M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | Citadel Advisors ✦ | 1.71M | -8.8% | $7.28M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 13 | Geode Capital Management ✦ (passief) | 1.33M | +22.4% | $5.65M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 14 | Geode Capital Management ✦ (passief) | 1.33M | +22.4% | $5.65M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 15 | Millennium Management ✦ | 1.27M | +29.9% | $5.41M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 16 | State Street Global Advisors ✦ (passief) | 1.05M | +21.5% | $4.48M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 17 | Wellington Management ✦ | 228.02K | -84.5% | $971,370 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 18 | Wellington Management ✦ | 228.02K | -84.5% | $971,370 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 19 | Wellington Management ✦ | 228.02K | -84.5% | $971,370 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 20 | Two Sigma Investments ✦ | 92.50K | +47.0% | $394,054 | 0.0% | ▲ Add | 5 | SEC ↗ |
| 21 | AQR Capital Management ✦ | 82.88K | +81.5% | $353,048 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 22 | AQR Capital Management ✦ | 82.88K | +81.5% | $353,048 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 23 | AQR Capital Management ✦ | 82.88K | +81.5% | $353,048 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 24 | AQR Capital Management ✦ | 82.88K | +81.5% | $353,048 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 25 | Renaissance Technologies ✦ | 58.80K | -9.0% | $250,488 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 26 | T. Rowe Price ✦ | 29.86K | +70.3% | $128,000 | 0.0% | ▲ Add | 5 | SEC ↗ |
| 27 | Fidelity (FMR) ✦ | 28.24K | — | $120,307 | 0.0% | n/c | 1 | SEC ↗ |
| 28 | Marshall Wace ✦ | 12.80K | -96.0% | $54,528 | 0.0% | ▼ Trim | 5 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Geen nieuwe bijgehouden kopers dit kwartaal. |
Verlaten
| Point72 Asset Management | $5.42M | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 1 houders, 200.00K aandelen, $10,000 gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.